Businesses will be given until after the holidays to comply with federal vaccine mandates, according to new rules released by the Occupational Safety and Health Administration. Employees must be vaccinated by January 4 or comply with weekly testing regimens. (CNBC Weekly)

CAR-T cell therapies from Bristol Myers Squibb and Gilead Sciences have greater benefit for patients with B-cell lymphoma than current treatments, study results showed. Bristol’s Breyanzi improved survival by 65% compared to standard treatment and Gilead’s Yescarta did so by 60%. (STAT)

Moderna has dropped an mRNA program for its chikungunya virus antibody, the company said Thursday. The company did not provide a reason for the decision but said results from its Phase I study will soon be published. (Endpoints News)

The Centers for Medicare and Medicaid Services finalized the vaccine mandate for healthcare workers at facilities that participate in Medicare and Medicaid. In an emergency regulation issued Thursday, CMS said all eligible workers must be vaccinated by December 5. (

CVS Health is adding doctors to its payroll as part of its push to become a major healthcare provider. The company will create primary care practices staffed with physicians, CVS chief executive Karen Lynch said. (The Wall Street Journal)